Clague Laura (CIK 0001388773)

Latest company ownership

Shares held
35,655
Last filed at
May 12, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2018Q4 2025Q4
GNSS - Genasys Inc.
Role: Director
Shares held
2,000
Last filed at
Apr 27, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2008Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
May 10, 2022 May 12, 2022 Travere Therapeutics, Inc. CFO Sell 36.3 -2,200 -5.81% ✓ $47.3K
Feb 23, 2022 Feb 24, 2022 Genasys Inc. Director Sell 46.3 -13,716 -6.23% ✗ $43.1K
Jan 31, 2022 Feb 2, 2022 Travere Therapeutics, Inc. CFO Sell 91.3 +8,602 29.41% ✓ $33.9K
Jan 24, 2022 Jan 26, 2022 Travere Therapeutics, Inc. CFO Sell 32.5 -2,063 -6.59% ✓ $51.5K
Jan 10, 2022 Jan 12, 2022 Travere Therapeutics, Inc. CFO Sell 53.8 - 0.00% ✓ $205.5K
Aug 13, 2021 Aug 17, 2021 Travere Therapeutics, Inc. CFO Sell 91.3 +3,093 10.96% ✗ $24.1K
May 11, 2021 May 13, 2021 Travere Therapeutics, Inc. CFO Sell 25.0 -4,000 -12.41% ✓ $77.2K
Mar 10, 2021 Mar 12, 2021 Genasys Inc. Director Sell 46.3 -5,456 -3.11% ✗ $40.5K
Feb 5, 2021 Feb 9, 2021 Travere Therapeutics, Inc. CFO Sell 25.0 -4,500 -12.25% ✓ $141.7K
Feb 3, 2021 Feb 3, 2021 Travere Therapeutics, Inc. CFO Sell 25.0 -3,625 -10.11% ✓ $104.8K
Jan 31, 2021 Feb 2, 2021 Travere Therapeutics, Inc. CFO Sell 87.5 +1,375 3.99% ✓ $111.5K
Nov 23, 2020 Nov 25, 2020 Travere Therapeutics, Inc. CFO Sell 53.8 - 0.00% ✓ $174.7K
Nov 16, 2020 Nov 17, 2020 Travere Therapeutics, Inc. CFO Sell 10.0 -7,500 -27.81% ✓ $179.8K
Nov 11, 2020 Nov 13, 2020 Travere Therapeutics, Inc. CFO Sell 95.0 +7,500 38.51% ✓ $177.1K
Sep 23, 2020 Sep 23, 2020 Travere Therapeutics, Inc. CFO Sell 36.3 -1,500 -7.15% ✓ $27.7K
Sep 18, 2020 Sep 22, 2020 Travere Therapeutics, Inc. CFO Sell 86.3 +1,500 7.70% ✓ $27.9K
May 11, 2020 May 13, 2020 Travere Therapeutics, Inc. CFO Sell 28.8 -3,027 -13.45% ✓ $49.1K
Mar 10, 2020 Mar 12, 2020 Travere Therapeutics, Inc. CFO Sell 20.0 -4,000 -15.09% ✓ $60.1K
May 15, 2019 May 16, 2019 Travere Therapeutics, Inc. CFO Sell 23.8 -2,500 -15.63% ✓ $45.6K
Feb 11, 2019 Feb 13, 2019 Travere Therapeutics, Inc. CFO Sell 23.8 -2,033 -16.90% ✓ $43.6K
Dec 20, 2018 Dec 21, 2018 Travere Therapeutics, Inc. CFO Sell 10.0 -7,500 -38.40% ✓ $164.7K
Nov 14, 2018 Nov 16, 2018 Travere Therapeutics, Inc. CFO Sell 10.0 -7,500 -38.40% ✓ $180.1K
Sep 4, 2013 Sep 6, 2013 Genasys Inc. Director Sell 26.3 -9,400 -29.38% ✗ $14.5K
Dec 11, 2008 Dec 15, 2008 Genasys Inc. Director Buy 90.0 +2,000 100.00% ✗ $870